Anne O’Neill
About
Anne O’Neill is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Anne O’Neill has authored 89 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Oncology, 32 papers in Cancer Research and 24 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anne O’Neill's work include Breast Cancer Treatment Studies (26 papers), Cancer Treatment and Pharmacology (22 papers) and Glioma Diagnosis and Treatment (11 papers). Anne O’Neill is often cited by papers focused on Breast Cancer Treatment Studies (26 papers), Cancer Treatment and Pharmacology (22 papers) and Glioma Diagnosis and Treatment (11 papers). Anne O’Neill collaborates with scholars based in United States, United Kingdom and Switzerland. Anne O’Neill's co-authors include George W. Sledge, Joseph A. Sparano, Kathy D. Miller, David Quiceno, Michael B. Atkins, James W. Mier, Jovanny Zabaleta, Augusto C. Ochoa, Sabina Signoretti and David F. McDermott and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.
In The Last Decade
Anne O’Neill
86 papers receiving 3.5k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Anne O’Neill United States | 30 | 1.8k | 979 | 822 | 620 | 587 | 89 | 3.5k | ||
| Jill Gilbert United States | 33 | 2.1k 1.2× | 568 0.6× | 1.2k 1.5× | 633 1.0× | 1.1k 2.0× | 91 | 4.5k | ||
| Vincenzo Tombolini Italy | 36 | 1.5k 0.8× | 515 0.5× | 1.4k 1.7× | 180 0.3× | 953 1.6× | 224 | 4.4k | ||
| Andrea Rocca Italy | 33 | 2.3k 1.2× | 1.3k 1.3× | 911 1.1× | 212 0.3× | 372 0.6× | 135 | 4.1k | ||
| Jean‐Pascal Machiels Belgium | 29 | 1.6k 0.9× | 482 0.5× | 1.1k 1.4× | 338 0.5× | 657 1.1× | 137 | 3.1k | ||
| Victoria Villaflor United States | 28 | 1.5k 0.8× | 404 0.4× | 1.2k 1.5× | 263 0.4× | 742 1.3× | 132 | 2.9k | ||
| Judith C. McCaffrey United States | 26 | 1.6k 0.9× | 649 0.7× | 491 0.6× | 2.4k 3.9× | 768 1.3× | 42 | 4.6k | ||
| Seungwon Kim United States | 36 | 1.8k 1.0× | 388 0.4× | 831 1.0× | 562 0.9× | 1.5k 2.6× | 119 | 4.0k | ||
| Yazid Belkacémi France | 34 | 1.3k 0.7× | 1.4k 1.4× | 870 1.1× | 192 0.3× | 960 1.6× | 212 | 4.1k | ||
| Jean-Pascal Machiels Belgium | 18 | 2.0k 1.1× | 848 0.9× | 2.4k 2.9× | 988 1.6× | 457 0.8× | 36 | 4.5k | ||
| Steven Powell United States | 21 | 2.6k 1.4× | 305 0.3× | 1.6k 1.9× | 608 1.0× | 575 1.0× | 91 | 3.6k |
Countries citing papers authored by Anne O’Neill
Since
Specialization
Citations
This map shows the geographic impact of Anne O’Neill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne O’Neill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne O’Neill more than expected).
Fields of papers citing papers by Anne O’Neill
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Anne O’Neill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne O’Neill. The network helps show where Anne O’Neill may publish in the future.
Co-authorship network of co-authors of Anne O’Neill
This figure shows the co-authorship network connecting the top 25 collaborators of Anne O’Neill. A scholar is included among the top collaborators of Anne O’Neill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne O’Neill. Anne O’Neill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Qin, Tingting, Austin K. Mattox, Jean S. Campbell, et al.. (2025). Epigenetic therapy sensitizes anti–PD-1 refractory head and neck cancers to immunotherapy rechallenge. Journal of Clinical Investigation. 135(6).
2.
Schiff, David, Anne O’Neill, Paul D. Brown, et al.. (2024). LTBK-07. PROGRESSION-FREE AND OVERALL SURVIVAL RESULTS OF ECOG-ACRIN E3F05: A PHASE 3 INTERGROUP TRIAL OF RADIATION ± TEMOZOLOMIDE FOR GRADE II GLIOMAS. Neuro-Oncology. 26(Supplement_8). viii1–viii2.
3.
Hanna, Glenn J., Anne O’Neill, Kartik Sehgal, et al.. (2024). Duvelisib with docetaxel for patients with anti-PD-1 refractory, recurrent, or metastatic head and neck squamous cell carcinoma.. Journal of Clinical Oncology. 42(16_suppl). 6031–6031.
4.
Bottinor, Wendy, Yael Flamand, Naomi B. Haas, et al.. (2023). Cardiovascular Implications of Vascular Endothelial Growth Factor Inhibition Among Adolescents/Young Adults in ECOG-ACRIN E2805. Journal of the National Comprehensive Cancer Network. 21(7). 725–731.e1.
5.
Haykal, Siba, S. Juvet, Anne O’Neill, et al.. (2023). Assessment of Acute Rejection in a Lung Transplant Recipient Using a Sentinel Skin Flap. Transplant International. 36. 11166–11166.
6.
Sparano, Joseph A., Anne O’Neill, Noah Graham, et al.. (2022). Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer. npj Breast Cancer. 8(1). 16–16.
7.
Schneider, Bryan P., Fei Shen, Guanglong Jiang, et al.. (2017). Impact of Genetic Ancestry on Outcomes in ECOG-ACRIN-E5103. PubMed Central.
8.
Leung, Katherine, et al.. (2017). Jugulodigastric lymph node size by age on CT in an adult cancer-free population. Clinical Imaging. 47. 30–33.
9.
Schneider, Bryan P., Fei Shen, Laura Gardner, et al.. (2016). Genome-Wide Association Study for Anthracycline-Induced Congestive Heart Failure. Clinical Cancer Research. 23(1). 43–51.
10.
Gardner, Laura, Fei Shen, Milan Radovich, et al.. (2016). Genome wide association study for anthracycline-induced congestive heart failure.. Journal of Clinical Oncology. 34(15_suppl). 1017–1017.
11.
Baxter, Nancy N., Jennifer M. Jones, Kelly Metcalfe, et al.. (2013). Pre-consultation educational group intervention to improve shared decision-making in postmastectomy breast reconstruction: study protocol for a pilot randomized controlled trial. Trials. 14(1). 199–199.
12.
Arteaga, Carlos L., Ingrid A. Mayer, Anne O’Neill, et al.. (2012). A randomized phase III double-blinded placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-overexpressing metastatic breast cancer (HER2+ MBC): A trial of the Eastern Cooperative Oncology Group (E1105).. Journal of Clinical Oncology. 30(15_suppl). 605–605.
13.
Bhatt, Rupal S., Xiaoen Wang, Liang Zhang, et al.. (2009). Abstract #153: Cox-2 inhibition delays resistance to sunitinib in RCC xenograft models. Cancer Research. 69. 153–153.
14.
Arteaga, Carlos L., Anne O’Neill, Stacy L. Moulder, et al.. (2008). A Phase I-II Study of Combined Blockade of the ErbB Receptor Network with Trastuzumab and Gefitinib in Patients with HER2 (ErbB2)-Overexpressing Metastatic Breast Cancer. Clinical Cancer Research. 14(19). 6277–6283.
15.
Goldstein, Lori J., Anne O’Neill, Joseph A. Sparano, et al.. (2008). Concurrent Doxorubicin Plus Docetaxel Is Not More Effective Than Concurrent Doxorubicin Plus Cyclophosphamide in Operable Breast Cancer With 0 to 3 Positive Axillary Nodes: North American Breast Cancer Intergroup Trial E 2197. Journal of Clinical Oncology. 26(25). 4092–4099.
16.
Wright, Mary, Julia Park, Jane V. Fey, et al.. (2007). Perpendicular Inked Versus Tangential Shaved Margins in Breast-Conserving Surgery: Does the Method Matter?. Journal of the American College of Surgeons. 204(4). 541–549.
17.
Robins, H. Ian, Anne O’Neill, Mark R. Gilbert, et al.. (2007). Effect of dalteparin and radiation on survival and thromboembolic events in glioblastoma multiforme: a phase II ECOG trial. Cancer Chemotherapy and Pharmacology. 62(2). 227–233.
18.
Basser, Russell L., Anne O’Neill, Giovanni Martinelli, et al.. (2006). Multicycle Dose-Intensive Chemotherapy for Women With High-Risk Primary Breast Cancer: Results of International Breast Cancer Study Group Trial 15-95. Journal of Clinical Oncology. 24(3). 370–378.
19.
Zea, Arnold H., Paulo C. Rodrı́guez, Michael B. Atkins, et al.. (2005). Arginase-Producing Myeloid Suppressor Cells in Renal Cell Carcinoma Patients: A Mechanism of Tumor Evasion. Cancer Research. 65(8). 3044–3048.
20.
Davidson, Nancy E., Anne O’Neill, Allen M. Vukov, et al.. (2005). Chemoendocrine Therapy for Premenopausal Women With Axillary Lymph Node–Positive, Steroid Hormone Receptor–Positive Breast Cancer: Results From INT 0101 (E5188). Journal of Clinical Oncology. 23(25). 5973–5982.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Jill Gilbert Breakdown of academic impact, for papers by Vincenzo Tombolini Breakdown of academic impact, for papers by Andrea Rocca Breakdown of academic impact, for papers by Jean‐Pascal Machiels Breakdown of academic impact, for papers by Victoria Villaflor Breakdown of academic impact, for papers by Judith C. McCaffrey Breakdown of academic impact, for papers by Seungwon Kim Breakdown of academic impact, for papers by Yazid Belkacémi Breakdown of academic impact, for papers by Jean-Pascal Machiels Breakdown of academic impact, for papers by Steven Powell